Botanical species · safety record

Passiflora foetida

The EFSA Compendium of Botanicals holds 7 constituent measurements and 4 adverse-effect records for Passiflora foetida. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Passiflora foetida L.

7Constituent measurements
4Safety records
7Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Tannins2
  • Alkaloids1
  • Calcium oxalate1
  • Cyanogenic glycosides1
  • Phlobotannins1
  • Saponins1

Plant parts

  • Leaves8
  • Unspecified2
  • Aerial part of plants1

Preparations

  • Solvent extraction8
  • Fresh2

Effect types

  • Systemic2
  • Endocrine1
  • Other toxicities1

Target tissues

  • Glandular1
  • Uterus1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsUnspecifiedSolvent extraction—Phytochemical screeningResolve DOI
Cyanogenic glycosidesAerial part of plantsSolvent extraction—Nuclear Magnetic Resonance (NMR) and Electron Spin Resonance (ESR) spectroscopyResolve DOI
TanninsUnspecifiedSolvent extraction—Phytochemical screeningResolve DOI
Calcium oxalateLeaves———No resolvable identifier
PhlobotanninsLeavesSolvent extraction—Phytochemical screeningNo resolvable identifier
SaponinsLeavesSolvent extraction—Phytochemical screeningNo resolvable identifier
TanninsLeavesSolvent extraction—Phytochemical screeningNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
EndocrineUterusLeavesSolvent extractionRat (as animal)Short-term toxicityNo resolvable identifier
Other toxicitiesGlandularLeavesSolvent extractionRat (as animal)Chronic/long term toxicityNo resolvable identifier
Systemic—LeavesFreshGoat (as animal)Case reportNo resolvable identifier
Systemic—LeavesFreshGoat (as animal)Case reportNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Carvalho, Fabricio K. de L., de Medeiros, Rosane M. T., de Araujo, Jose A. S., Riet-Correa, Franklin. Experimental poisoning by Passiflora foetida (Passifloraceae) in goats. Pesquisa veterinaria brasileira, 2011, vol. 31, no. 6, p. 477-481.
  2. Chivapat, S., Bunjob, M., Shuaoprom, A., Bansidhi, J., Chavalittumrong, P., Rangsripipat, A., Sincharoenpokai, P. Chronic toxicity of Passiflora foetida L. extract. International journal of applied research in natural products, 2011, vol. 4, no. 2, p. 24-31.
  3. Michel, Bleu Gome., Koffi, Kouakou., Alassane, Toure., Flavien, Traore. Effects of Passiflora foetida Linn. (Passifloraceae) on Genital Tract, Serum Estradiol, Pituitary Gonadotropin and Prolactin Level in Female Adult and Immature Ovariectomized Rats. B-Biological Sciences, 2012, vol. 55, no. 3, p. 138-144.
  4. Linga, R.C.R., Dhachinamoorthi, D., Chandrasekhar, K.B., Chellaram, S. Pharmacognostical studies on leaves of Passiflora foetida linn. International Journal of Research in Pharmaceutical Sciences, 2014, vol. 5, no. 1, p. 59-63.
  5. Andersen, Lise., Adsersen, Anne., Jaroszewski, Jerzy W. Natural cyclopentanoid cyanohydrin glycosides: Cyanogenesis of Passiflora foetida . Phytochemistry (oxford), 1998, vol. 47, no. 6, p. 1049-1050. DOI
  6. Siriwardhene, M. A., Abeysekera, A. M., Chandrika, U. G., Goonetilleke, A. K. E. Antihyperglycemic effect and phytochemical screening of aqueous extract of Passiflora foetida (Linn.) on normal Wistar rat model. African journal of pharmacy and pharmacology, 2013, p. 2892-2894.
  7. Asadujjaman, Md., Mishuk, Ahmed Ullah., Hossain, Md Aslam., Karmakar, Utpal Kumar. Medicinal potential of Passiflora foetida L. plant extracts: biological and pharmacological activities.. Journal of integrative medicine, 2014, vol. 12, no. 2, p. 121-6. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue